Antiviral treatment of recurrent hepatitis C after liver transplantation
Open Access
- 22 February 2005
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 41 (3) , 436-438
- https://doi.org/10.1002/hep.20623
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Donor age influences 10-year liver graft histology independently of hepatitis C virus infectionJournal of Hepatology, 2004
- Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combinationJournal of Hepatology, 2004
- Mechanisms of HCV reinfection and allograft damage after liver transplantationJournal of Hepatology, 2004
- Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantationJournal of Hepatology, 2003
- Hepatitis C virus kinetics during and immediately after liver transplantationHepatology, 2002
- Genetic Clustering of Hepatitis C Virus Strains and Severity of Recurrent Hepatitis after Liver TransplantationJournal of Virology, 2001
- Recurrent hepatitis C after liver transplantation: A nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirinLiver Transplantation, 2001
- High Incidence of Allograft Cirrhosis in Hepatitis C Virus Genotype 1B Infection Following Transplantation: Relationship With Rejection EpisodesHepatology, 1999
- Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantationGastroenterology, 1995
- Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantationHepatology, 1995